...
首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Interactions between tenofovir and nevirapine in CD4+ T cells and: Monocyte-derived macrophages restrict their intracellular accumulation
【24h】

Interactions between tenofovir and nevirapine in CD4+ T cells and: Monocyte-derived macrophages restrict their intracellular accumulation

机译:替诺福韦和奈韦拉平在CD4 + T细胞中的相互作用和:单核细胞衍生的巨噬细胞限制其细胞内积累

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: There is no pharmacokinetic interaction between tenofovir and nevirapine, but a higher emergence rate of resistance mutations has been reported when these drugs are coadministered. We sought to examine if there is a potential intracellular interaction that may account for the emergence of resistant virus. Methods: Primary CD4+ and CD14+ cells were isolated from healthy volunteer blood. Monocyte-derived macrophages were differentiated from CD14+ cells. Accumulation of radiolabelled tenofovir and nevirapine was then assessed in these cells. Results: We show here that tenofovir and nevirapine immune cell intracellular concentrations are lower when coincubated in CD4+ cells and monocyte-derived macrophages, but not in CD14+ cells. Conclusions: These data indicate a potential intracellular drug-drug interaction between these drugs that warrants further investigation.
机译:目的:替诺福韦和奈韦拉平之间没有药代动力学相互作用,但是有报道称这些药物联合使用时耐药突变的出现率更高。我们试图检查是否存在潜在的细胞内相互作用,可能解释了抗药性病毒的出现。方法:从健康志愿者血液中分离原代CD4 +和CD14 +细胞。单核细胞衍生的巨噬细胞从CD14 +细胞中分化出来。然后评估这些细胞中放射性标记的替诺福韦和奈韦拉平的积累。结果:我们在这里显示,当在CD4 +细胞和单核细胞衍生的巨噬细胞中共同孵育时,替诺福韦和奈韦拉平免疫细胞的细胞内浓度较低,而在CD14 +细胞中则没有。结论:这些数据表明这些药物之间潜在的细胞内药物相互作用,值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号